Related Experiment Video
Updated: Jun 12, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
The emerging role for chemokines in epilepsy
Paolo F Fabene1, Placido Bramanti, Gabriela Constantin
1Department of Morphological and Biomedical Sciences, Section of Anatomy and Histology, University of Verona, Verona, Italy. paolo.fabene@univr.it
Inflammation, particularly involving leukocytes and chemokines, plays a crucial role in epilepsy development. This research highlights the importance of non-neuronal cells in the epileptogenic process.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Epilepsy traditionally viewed as a neuronal disorder.
- Emerging evidence implicates non-neuronal cells like astrocytes and microglia.
- Blood-brain barrier dysfunction and leukocyte involvement are increasingly recognized.
Purpose of the Study:
- To investigate the role of non-neuronal cells in epilepsy pathogenesis.
- To explore the significance of leukocyte-endothelium interactions.
- To understand the potential role of chemokines in epileptogenesis.
Main Methods:
- Review of recent evidence on neuroinflammation in epilepsy.
- Analysis of leukocyte migration and recruitment mechanisms.
- Focus on chemokine involvement in the epileptogenic cascade.
Main Results:
- Growing evidence supports the involvement of astrocytes, microglia, and leukocytes.
- Leukocyte-endothelium interactions are key in epileptogenesis.
- Pro-inflammatory chemokines are implicated in epilepsy development.
Conclusions:
- Non-neuronal cells, particularly leukocytes, are critical in epilepsy.
- Chemokines likely play a significant role in the inflammatory processes driving epilepsy.
- Further research into neuroinflammation is vital for understanding and treating epilepsy.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures l: Introduction